Noetik Raises $14 Million Seed Financing to Revolutionize Cancer Immunotherapy Using Artificial Intelligence
DCVC led the round to support Noetik’s mission to redefine cancer drug development using spatial biology and machine learning Noetik is building one of the largest, most differentiated clinical datasets in the industry to drive precision immune therapies Noetik, an AI drug discovery company leveraging machine learning and proprietary human......